Publication | Closed Access

Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder

PsychiatryPsychotic DisorderAddictionMedicinePsychopharmacologySchizophreniaNeuropharmacologySocial SciencesPharmacotherapyPlacebo-controlled Multicenter TrialDopaminePharmacologySchizoaffective DisorderPsychopathology